Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T9RD
|
||||
Former ID |
DNC008315
|
||||
Drug Name |
(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529319] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H51NO
|
||||
Canonical SMILES |
CCCCCCCCC=CCCC(CCCC(C(C)C)C(=O)NC1=CC=CC=C1)C(C)C
|
||||
InChI |
1S/C30H51NO/c1-6-7-8-9-10-11-12-13-14-16-20-27(25(2)3)21-19-24-29(26(4)5)30(32)31-28-22-17-15-18-23-28/h13-15,17-18,22-23,25-27,29H,6-12,16,19-21,24H2,1-5H3,(H,31,32)/b14-13-
|
||||
InChIKey |
HUQXXTSZFWLRDE-YPKPFQOOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetyl-CoA acetyltransferase, mitochondrial | Target Info | Inhibitor | [529319] | |
KEGG Pathway | Fatty acid degradation | ||||
Synthesis and degradation of ketone bodies | |||||
Valine, leucine and isoleucine degradation | |||||
Lysine degradation | |||||
Tryptophan metabolism | |||||
Pyruvate metabolism | |||||
Glyoxylate and dicarboxylate metabolism | |||||
Propanoate metabolism | |||||
Butanoate metabolism | |||||
Terpenoid backbone biosynthesis | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Carbon metabolism | |||||
Fatty acid metabolism | |||||
NetPath Pathway | Leptin Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.